Population planning for alcohol and other drug services: the national Drug and Alcohol Clinical Care & Prevention (DA-CCP) project

Similar documents
Manuscript Title: Estimating Treatment Rates for Mental Disorders in Australia

The Network of Alcohol and other Drugs Agencies (NADA) is the peak organisation for the non government alcohol and other drugs sector in NSW.

Models of good practice in drug treatment in Europe. Project group

2002 AUSTRALIAN BUREAU OF STATISTICS DATA ON ACCIDENTAL DRUG-INDUCED DEATHS DUE TO OPIOIDS

Young people and AOD Strategies and support. Eden Wheatley (Program Coordinator)

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

Opiate Dependency bka Opioid Addiction

DRUGS, ALCOHOL & MENTAL HEALTH, HOW THEY CONNECT

Drug-related hospital stays in Australia

Drug-related hospital stays in Australia

Keyfacts - Substance use

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Opioid Substitution Treatment in Christchurch

National Guidelines. Interim methadone prescribing

Cancer in Australia: Actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 2012

St Vincent s Hospital Sydney, Drug and Alcohol Service, S-Check Clinic

Primary Health Networks

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

NZ Organised Stroke Rehabilitation Service Specifications (in-patient and community)

Public Health Association of Australia: Policy-at-a-glance Pharmaceutical Drug Misuse Policy

MI and CBT to reduce substance use problems and improve mental health and well-being Amanda Baker PhD

Drug related hospital stays in Australia

What is harm reduction?

Appendix 1: Data elements included in the AODTS NMDS for

Early Psychosis Services across Australia

HA Corporate Scholarship Program:

Substance use and misuse

Updated Activity Work Plan : Drug and Alcohol Treatment NEPEAN BLUE MOUNTAINS PHN

Addressing Drug Addiction in Australia

What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

Pharmacotherapy. Position Paper: Pharmacotherapy. Introduction. Victorian Alcohol and Drug Association (VAADA) Issued August 2011

Statement about the release of the National Ice Taskforce Report, release of two Review report and various announcements by the Australian Government

ATLAS on substance use 2017:

Alcohol health promotion utilising a harm minimisation approach PREVENTIVE HEALTH MATTERS WEBINAR

Western NSW Drug and Alcohol Needs Assessment

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Methadone and buprenorphine for the management of opioid dependence

The Woodlands Managing Alcohol To Support Recovery In Mental Health

Concurrent Disorders. Case Management: Making It Work Ontario Harm Reduction Distribution Conference February 2013

This webinar is presented by

ALCOHOL DEPENDENCE SYNDROME AND OTHER PSYCHIATRIC ILLNESSESS

Drug Misuse and Dependence Guidelines on Clinical Management

ALCOHOL AND DRUGS PLANNING FRAMEWORK

Primary Health Network Needs Assessment Reporting Template

1. MULTIDISCIPLINARY TEAM MANAGEMENT

Methamphetamine Use in Australia: What the data tells us about patterns of use & users. methamphetamine

22 April 2002 Central Australian Aboriginal Congress Submission: Taskforce on Illicit Drugs

Alcohol, drug and related health and wellbeing issues among young people completing an online screen.

Tobacco addiction: time to clear the air

LOGBOOK ADVANCED TRAINING PSYCHIATRY OF OLD AGE. To be completed with the GENERALIST logbook (for pre FRANZCP Advanced Trainees)

Arcadia House Programs Continuum of Care. Presenter Belinda Grooms - Arcadia House Case Manager

Harm Reduction. Supporting Evidence. What is Harm Reduction? Benefits of Harm Reduction

North Coast Primary Health Network Drug and Alcohol Treatment Updated Activity Work Plan

Cocaine and Methamphetamine related drug-induced deaths in Australia, 2011

Position is based Access Health & Community: Hawthorn and Doncaster East Manager, Alcohol and Other Drug Service

COGNITION IN DRUG AND ALCOHOL SERVICES

ATOP. Australian Treatment Outcome Profile. Presented by Lan Wu & Elly Staunton-McKenzie. Special Thanks to Alan Gude & Linda Hipper

NADAbase Snapshot Report 15/16

Welcome to your Addiction Recovery Community Hub. Patient information leaflet ARCH North

Self Provision of Alcohol and Drugs Ottawa s Managed Alcohol Program: A Fundamental Component of an Overarching Strategy for the Care of the Homeless

Influenza Surveillance to Inform Decision Making

Submission to Parliamentary Joint Committee on Law Enforcement Inquiry into Crystal Methamphetamine (Ice)

EVALUATION OF THE CARESEARCH GP WEBPAGES. Christine Sanderson Associate Professor Geoff Mitchell Jennifer Tieman

ORGANIZATION OF AMERICAN STATES

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

WELCOME TO THE CRACKS IN THE ICE WEBINAR SERIES

Wear Recovery. Sunderland Integrated Drug & Alcohol Services

Community Programs & Minimising Frailty in Older People

The Quality Gap in Mental Health Treatment in Australia

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

Updated Activity Work Plan : Drug and Alcohol Treatment

Ruth A Parslow, Virginia Lewis and Geraldine Marsh

Depression & Alcohol

Dementia in Australia

Overview of the Australian National Drug Strategy Household Survey (NDSHS)

Primary Health Networks

PERSPECTIVES ON DRUGS Characteristics of frequent and high-risk cannabis users

Alcohol burden on Accident & Emergency Departments: Implications for policy and practice. Dr. Tom Phillips, PhD. The MCA Symposium 16 th November 2016

Addressing the Opioid Epidemic in the Veterans Health Administration

Public Health Association of Australia: Policy-at-a-glance Pharmaceutical Drug Misuse Policy

MENTAL HEALTH SUPPORT

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Indigenous Eye Health Indicators

OUTCOMES OF TRAINING GENERAL PRACTITIONERS TO PRESCRIBE METHADONE

Strict 5 minute limit. Abstract Session. Don t forget to vote for the best abstract

illicit drug reporting system drug trends bulletin Key findings from the 2015 IDRS: a survey of people who inject drugs Introduction

Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version

Page 1 of 11. Effective 9/15/2018 AUTHORIZATION REQUIREMENT LEVEL OF CARE. Notes (0 = No Additional Comments)

NSW Health Plan for Prevention of Falls and Harm from Falls Among Older People: Joanne Smith Director Centre for Health Advancement

SPINAL CORD INJURY Rehab Definitions Framework Self-Assessment Tool inpatient rehab Survey for Spinal Cord Injury (SCI)

Final Report Emotional Wellbeing Project (Wellbeing Plus Course)

Mental health and Aboriginal people and communities

CURRENT TOBACCO SMOKING BY THE NSW POPULATION AND THE CONSEQUENCES FOR HEALTH

OPPORTUNITIES FOR ADDRESSING SMOKING IN SUBSTANCE ABUSE TREATMENT

S 0332 S T A T E O F R H O D E I S L A N D

Young onset dementia service Doncaster

25 September 2012 Early Years Pathfinder. misuse. Insert name of presentation on Master Slide. Presenter: Dr Sarah J Jones

CESPHN Webinar. Using opioid agonist treatment for pharmaceutical opioid dependence

Transcription:

Population planning for alcohol and other drug services: the national Drug and Alcohol Clinical Care & Prevention (DA-CCP) project

History and context Service planning poorly done How many services do we need? What types do we need? Where do we need them? Past & current attempts to plan for treatment Often based on historical funding (supply = demand) Little research on unmet demand No systematic agreement about treatment types and best practice standards No estimates of potential resources required

Drug and Alcohol Clinical Care & Prevention (DA-CCP) DA-CCP an endeavour to overcome this Build a national planning model Develop standard types of care and identify their components DA-CCP based on an earlier NSW mental health planning model (Pirkis et al., 2007)

DA-CCP Aims and Objectives To build the first national population based model for drug and alcohol service planning To estimate the need and demand for services To use clinical evidence and expert consensus to specify the care packages required by individuals and groups To calculate the resources needed to provide these care packages To provide a tool for jurisdictions: the development of a national model that can be adapted for use within each Australian jurisdiction (transparency and consistency in service planning) Work in progress model outputs not yet available.

The DA-CCP model The model is about what should be, not what currently is Five drug classes (alcohol, opiates, cannabis, methamph & benzos) Five age groups (0-11mnths; 1-11 yrs; 12-17 yrs; 18-64 yrs; 65+) Care packages: range of service types: Outpatient, community based treatments Residential rehabilitation services Inpatient, hospital based treatments Inpatient, community based treatments Primary care services (eg. GPs) Care packages are evidence based. In the absence of evidence, then care packages are based on expert consensus Where not included: not a geographical resource distribution formula

What will DA-CCP tell us Nationally shared descriptions of units of service (care packages) Estimates of: The # of people needing treatment (by drug type and by age range) The # of staff (FTE) required (medical, allied health/nursing, AOD workers) The # of beds; treatment places required The amount of other care (doses of meds, medical investigations etc) A tool for each jurisdiction to use in planning for AOD services

The epidemiology Derived from National Survey of Mental Health and Wellbeing (1997) Nationally representative, face-to-face survey of 10,641 individuals, 18-85 yrs DSM-IV and ICD-10 diagnoses Those who meet diagnostic criteria for abuse or dependence Separated into mild, moderate and severe Based on disability weights from Burden of Disease work (Begg et al., 2007) Perceived need/demand - treatment rate for mild, moderate and severe Mild 20-25% Moderate 65-75% Severe 100% Based on overall best treatment prevalence of 51% (Tolkien report)

Care packages The care for a person for a year is defined in terms of: the drug type the age group the severity of presentation (mild, moderate, severe) And for each of these: frequency & duration of sessions (outpatient treatments) type of clinician (FTE time) number of bed days & occupancy rate The level of care that is specified for an average person is adequate, anything less would be unsatisfactory.

What are the alcohol care packages? 1. Psychosocial interventions - without RP meds - standard 2. Psychosocial interventions - with RP meds - standard 3. Psychosocial interventions - without RP meds - complex 4. Psychosocial interventions - with RP meds - complex 5. Withdrawal - home based - standard - without RP meds 6. Withdrawal - daily outpatient - standard without RP meds 7. Withdrawal - daily outpatient - standard with RP meds 8. Withdrawal - daily outpatient - complex - with RP meds 9. Withdrawal - residential - standard - with RP meds 10. Withdrawal - residential - complex - with RP meds 11. Rehabilitation - day program - 25 days - standard 12. Residential rehabilitation - 8 week stay 13. Residential rehabilitation - 13 week stay 14. Residential rehabilitation - 26 week stay

What are the opioid care packages? 1. Opioid maintenance treatment - standard 2. Opioid maintenance treatment - complex 3. Psychosocial interventions - standard 4. Psychosocial interventions - complex 5. Withdrawal - daily outpatient - standard 6. Withdrawal - daily outpatient - complex 7. Withdrawal - residential - standard 8. Withdrawal - residential - complex 9. Rehabilitation - day program - 25 days - standard 10. Residential rehabilitation - 8 week stay 11. Residential rehabilitation - 13 week stay 12. Residential rehabilitation - 26 week stay 13. Residential rehabilitation - methadone to abstinence 14. Residential rehabilitation - stabilisation program

Example: Opioid care package, maintenance treatment Induction Maintenance Individual psychosocial interventions Dosing, tobacco intervention, assertive follow-up

Additional care that we spread across the model Consultation/liaison services in hospitals (ED and acute) Harm reduction services (eg Needle Syringe programs) Services for pregnant woman with AOD disorders Early and brief interventions Telephone services Prevention activities & programs

Challenges 1. Epidemiology Epidemiology is dated (and inaccurate for low prevalence, eg opioid dependence) Treated prevalence expert judgment, plus disability weights Allocation to care packages expert consensus plus existing utilisation 2. Care components High quality evidence for some care packages is lacking Evidence for prevention is lacking 3. Other issues Co-morbidity Not all drugs covered (eg pharmaceutical opioids) Indigenous module

Conclusions Progressive approximations towards a sensible model First endeavour will be built on in subsequent iterations Internationally cutting edge only one other nation attempting work in this area (Canada) Capacity to transform Australian planning of AOD services

Thank-you Professor Alison Ritter Drug Policy Modelling Program, Director National Drug and Alcohol Research Centre UNSW, Sydney, NSW, 2052, Australia E: alison.ritter@unsw.edu.au T: + 61 (2) 9385 0236 DPMP Website: http://www.dpmp.unsw.edu.au

References Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing users guide, 1997. Canberra: Australian Bureau of Statistics, 1999 Slade, T., Johnston, A., Oakley-Browne, M. A., Andrews, G., & Whiteford, H. (2009). 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Australian and New Zealand Journal of Psychiatry, 47, 594-605. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez AD, 2007. The burden of disease and injury in Australia 2003. PHE 82. Canberra: AIHW. Pirkis J. Harris M. Buckingham W. Whiteford H. Townsend-White C. International planning directions for provision of mental health services. Administration & Policy in Mental Health, 2007; 34(4):377-87.